CLINICAL_TRIALS
trial_result
· 2023-10-17
Clinical Trial Update: Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis [Phase 4]
Summary
Phase 4 clinical trial update evaluating dupilumab in pediatric patients with atopic dermatitis, focusing on skin barrier function and lipidomics; results have …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Dermatitis Atopic | Phase 4 | Status: COMPLETED | Results posted: 2023-10-17